Browsing by Author Coleman, Robert

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
20072-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.Wilcken, Nicholas; Baselga, Jose (Prof); Bell, Richard (Prof); Bergh, Jonas (Prof); Cameron, David; Coleman, Robert; Dowsett, Mitch (Prof); Feyereislova, Andrea; Gelber, Richard D. (Prof); Gelmon, Karen (Prof); Goldhirsch, Aron (Prof); Guillaume, Sebastien; Harbeck, Nadia; Kaufmann, Manfred (Prof); Lopez, Roberto I; Mallmann, Peter (Prof); Mariani, Gabriella; Piccart-Gebhart, Martine J (Prof); Procter, Marion; Sanchez Rovira, Pedro; Smith, Ian (Prof); Untch, Michael (Prof); Wardley, Andrew; Wist, Erik (Prof); Western Clinical School: Medicine (Westmead)2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial., The Lancet, vol.369,(9555),2007,pp 29-36
2013Hydroxyapatite mineralization in the presence of anionic polymersPerrier, Sebastien; Coleman, Robert; Grondahl, Lisbeth; Jack, Kevin; ChemistryHydroxyapatite mineralization in the presence of anionic polymers, Crystal Growth and Design, vol.13, 10, 2013,pp 4252-4259
2017Long-term follow-up of The Intergroup Exemestane StudyCoates, Alan; Alvarez, Isabel; Andersen, Jorn; Bertelli, Gianfilippo; Bliss, Judith; Coleman, Robert; Coombes, R. Charles; Del Mastro, Lucia; Dodwell, David; Fallowfield, L. J.; Holmberg, Stig; Jassem, Jacek; Jones, Stephen E; Kilburn, L; L√łnning, Per; Morden, James; Nicholas, Hanna; Ortmann, Olaf; Paridaens, Robert; Snowdon, Claire; van de Velde, C; NH&MRC Clinical Trials CentreLong-term follow-up of The Intergroup Exemestane Study, Journal of Clinical Oncology, vol.35, 22, 2017,pp 2507-2514
2015A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancerHart, Derek; Coleman, Robert; D'Rozario, Rachael; et al, Various; Hardy, Melinda; Prue, R; Radford, Kristen; Rossetti, T; Tong, Hui; Tracey, Christopher; Vari, F; Waterhouse, Nigel; Concord Clinical School: ANZAC Research InstituteA phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancer, Journal of Immunotherapy, vol.38, 2, 2015,pp 71-76